110 results
Page 5 of 6
8-K
EX-1.1
15zdg5ew6kl2 rk5ryw
21 Sep 18
Viking Therapeutics Announces Pricing of $175.8 Million Public Offering of Common Stock
6:05am
424B5
rky471io lrbz
19 Sep 18
Prospectus supplement for primary offering
4:27pm
8-K
EX-99.1
qg6s3pg
9 Aug 18
Viking Therapeutics Reports Second Quarter 2018 Financial Results and Provides Corporate Update
12:00am
424B5
n5yw2ao3w5z34q nnyc
7 Jun 18
Prospectus supplement for primary offering
5:13pm
8-K
EX-1.1
he370y6c6985a
7 Jun 18
Viking Therapeutics Announces Pricing of $67.5 Million Public Offering of Common Stock
1:41pm
424B5
hdquc4z 9ot07alxz
6 Jun 18
Prospectus supplement for primary offering
4:11pm
8-K
EX-99.1
74y614xzwp
9 May 18
Viking Therapeutics Reports First Quarter 2018 Financial Results and Provides Corporate Update
12:00am